| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/25/2001 | WO2001005390A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005356A2 Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant |
| 01/25/2001 | WO2001005253A1 Compositions, kits, and methods for providing and maintaining energy and mental alertness |
| 01/25/2001 | WO2001005250A1 Potassium calcium citrate compositions and methods for production |
| 01/25/2001 | WO2000066111B1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| 01/25/2001 | WO2000064893A3 Thiazolidinedione derivative and its use as antidiabetic |
| 01/25/2001 | WO2000064892A3 Thiazolidinedione derivative and its use as antidiabetic |
| 01/25/2001 | WO2000063205A3 Thiazolidinedione derivative and its use as antidiabetic |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | WO2000058293A3 Glucokinase activators |
| 01/25/2001 | WO2000057837A3 Compositions and methods for effecting the levels of cholesterol |
| 01/25/2001 | WO2000056356A3 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs) |
| 01/25/2001 | WO2000044740A3 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 01/25/2001 | DE19934433A1 New N-(indolyl-carbonyl)-N'-ethyl-piperazine derivatives, are 5-HT-2A receptor antagonists useful e.g. for treating schizophrenia, depression, Parkinson's disease, Alzheimer's disease or anorexia |
| 01/25/2001 | DE19933926A1 Biphenylderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenyl derivatives, their preparation and their use as medicaments |
| 01/25/2001 | CA2381327A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | CA2379983A1 Dsp-11 dual-specificity map kinase phosphatase |
| 01/25/2001 | CA2379847A1 Method for making debromohymenialdisine and analogs thereof |
| 01/25/2001 | CA2379489A1 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |
| 01/25/2001 | CA2379308A1 Fat-binding polymers, optionally combined with lipase inhibitors |
| 01/25/2001 | CA2379064A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | CA2378954A1 The il-1l1 gene and polypeptide products |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378917A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | CA2378202A1 New compounds |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2377718A1 1,2,3,4,5,6-hexahydroazepino¬4,5-b|indoles containing arylsulfones at the 9-position |
| 01/25/2001 | CA2377092A1 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | CA2376518A1 Conversion of a watson-crick dna to a hoogsteen-paired duplex |
| 01/25/2001 | CA2375980A1 Compositions, kits, and methods for providing and maintaining energy and mental alertness |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | CA2374052A1 Method for treating chronic pain using mek inhibitors |
| 01/24/2001 | EP1070727A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 01/24/2001 | EP1070707A1 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/24/2001 | EP1070703A1 Cyclobutene derivatives |
| 01/24/2001 | EP1070129A2 Dadd, death activator death domain protein |
| 01/24/2001 | EP1070084A1 PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase) |
| 01/24/2001 | EP1070069A1 Bicyclic hydroxamic acid derivatives |
| 01/24/2001 | EP1070065A1 Azabicyclic 5ht1 receptor ligands |
| 01/24/2001 | EP1070060A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 01/24/2001 | EP1070058A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/24/2001 | EP1070048A1 Calcilytic compounds |
| 01/24/2001 | EP1070046A1 Propanolamine derivatives |
| 01/24/2001 | EP1069905A1 Method and composition for lowering low density lipoprotein cholesterol |
| 01/24/2001 | EP1069901A1 Calcilytic compounds and method of use |
| 01/24/2001 | EP0788513B1 Use of binding agents to cd23 in the treatment of autoimmune diseases |
| 01/24/2001 | EP0788496B1 Apolipoprotein-b synthesis inhibitors |
| 01/24/2001 | EP0694039B1 1,5-benzodiazepine derivatives having cck antagonistic and or agonistic activity |
| 01/24/2001 | EP0662830B1 (pi)-BOND AROMATIC VITAMIN CHELATES |
| 01/24/2001 | EP0557498B1 Bone-growth-stimulating composition |
| 01/24/2001 | CN1281466A Aggregates of human insulin derivatives |
| 01/24/2001 | CN1281455A 8-Azabicyclo [3,2,1] octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors |
| 01/24/2001 | CN1281454A Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridil) amino) ethyoxy] benzyl] thiazolidine-2,4-dione maleic acid salt |
| 01/24/2001 | CN1281453A 5-[4-[2-(n-methyl-n-(2-pyridil) amino) ethoxy] benzyl] thiazolidine-2,4-dione, maleic acid salt, hydrate as pharmaceutical |
| 01/24/2001 | CN1281447A (i(E))-3-[1-i(n)-butyl-5-[2-(-carboxyphenyl) methoxy-4-chlorophenyl]-1i(H)-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl) methyl]-prop-2-enoic acid monoargininyl salt |
| 01/24/2001 | CN1281443A Bicyclic compounds, process for their preparation and pharmaceutical composition containing them |
| 01/24/2001 | CN1281441A Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors |
| 01/24/2001 | CN1281434A Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors |
| 01/24/2001 | CN1281431A Urethanes, thio and dithio analogues, salts thereof, medicaments containing said compounds, use and method for production thereof |
| 01/24/2001 | CN1281367A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 01/24/2001 | CN1281365A Composition and method for increasing insulin activity |
| 01/24/2001 | CN1281364A Compositions for weight reduction |
| 01/24/2001 | CN1281361A Use of aromatase inhibitor in treatment of uropoiesis disease and method for studying uropoiesis disease |
| 01/24/2001 | CN1281359A Use of thiazolidinediones for treatment of hyperglycaemia |
| 01/24/2001 | CN1281358A Use of thiazolidinediones for treatment of hyperglycaemia |
| 01/24/2001 | CN1280835A Chinese-medicinal capsule for treating hyperlipomia |
| 01/24/2001 | CN1061052C 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine |
| 01/24/2001 | CN1061049C Sulfur-containing phosphonate compounds, pharmaceutical compositions and use thereof |
| 01/24/2001 | CN1060956C Fat regulating tablet for treating hyperlipidemia and preparing method thereof |
| 01/23/2001 | US6177545 Antibody which preferentially binds an epitope of an enzymatic protein; for diagnosis of time events in tumor propagation and metastasis, autoimmune diseases, kidney defects and atherosclerotic injury |
| 01/23/2001 | US6177474 Aromatic compound containing ketone and hydroxy groups |
| 01/23/2001 | US6177470 Prostaglandin synthesis |
| 01/23/2001 | US6177454 Antidiabetic agents |
| 01/23/2001 | US6177453 Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus |
| 01/23/2001 | US6177451 For humans; parkinson's, tourelle's, and alzheimer's diseases |
| 01/23/2001 | US6177444 Allosteric adenosine receptor modulators |
| 01/23/2001 | US6177429 Dihydropyrazine derivatives as NPY antagonists |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177273 Antisense modulation of integrin-linked kinase expression |
| 01/23/2001 | CA2221767C A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component |
| 01/22/2001 | CA2746824A1 Neurotherapeutic composition and method |
| 01/22/2001 | CA2312203A1 Cyclobutene derivatives, their preparation and their therapeutic uses |
| 01/18/2001 | WO2001004341A1 Method for producing oligopolysaccharides |
| 01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004303A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 01/18/2001 | WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/18/2001 | WO2001004156A1 Peptides that lower blood glucose levels |
| 01/18/2001 | WO2001004133A1 Human eag2 |
| 01/18/2001 | WO2001004119A1 Amido spiropiperidines promote the release of growth hormone |
| 01/18/2001 | WO2001004116A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 01/18/2001 | WO2001004113A2 Process for the preparation of paroxetine and synthetic intermeditates thereof |
| 01/18/2001 | WO2001004110A1 Benzimidazole compounds |
| 01/18/2001 | WO2001004102A1 Quinazoline derivatives |
| 01/18/2001 | WO2001004099A1 Benzoylpyridazines |
| 01/18/2001 | WO2001004092A1 Process for the preparation of tricyclic amino alcohol derivatives |
| 01/18/2001 | WO2001003725A1 Use of interleukin-6 in treatment of obesity and/or obesity associated disorders |
| 01/18/2001 | WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | WO2001003705A1 Compositions and methods for raising hdl cholesterol levels |